May 25, 2017 announcements AI enabled research shows delay in onset of motor neurone disease Sheffield and London, UK - 25 May 2017. The Sheffield Institute for Translational Neuroscience (SITraN), part of the University of Sheffield and one of the world’s leading centres for research into Motor Neurone Disease, Alzheimer’s and Parkinson’s Disease, today announced that its research into a drug candidate discovered by British artificial intelligence firm BenevolentAI has delivered positive results. ARTIFICIAL INTELLIGENCE , DRUG DISCOVERY
Apr 11, 2017 announcements BenevolentAI agrees partnership with medical research charity MRC technology London, 11 April 2017 – BenevolentAI, a British artificial intelligence company, today announced that it has partnered with MRC Technology (“MRCT”), a medical research charity, to explore drug discovery initiatives in the field of small molecules and antibodies. DRUG DISCOVERY , SCIENCE , BIOMEDICAL , ARTIFICIAL INTELLIGENCE , BENEVOLENTAI
Feb 21, 2017 articles Bold claims for AI are hard to compute for economists The Financial Times takes a look at the work we’re doing at BenevolentAI to “revolutionise medical research” after speaking to Co-Founder and Director, Ken Mulvany. ARTIFICIAL INTELLIGENCE , TECH , BUSINESS , KEN MULVANY , DISRUPTIVE , TRENDS , BENEVOLENTAI
Jan 11, 2017 announcements British technology firm appointed to the global ‘AI 100’ for advancing artificial intelligence in drug discovery Revealed at the 2017 CB Insights Innovation Summit, Santa Barbara, California CB INSIGHTS , AI 100 , INNOVATION , UNICORN
Mar 20, 2017 articles BenevolentAI Q&A: Techworld meets Dr Jackie Hunter, CEO of BenevolentBio An interview with Jackie Hunter, CEO BenevolentBio, the drug discovery arm of BenevolentAI ARTIFICIAL INTELLIGENCE , DRUG DISCOVERY , BENEVOLENTBIO , JACKIE HUNTER
Dec 6, 2016 articles BenevolentBio’s artificial intelligence could discover a better treatment for ALS DRUG DISCOVERY , ARTIFICIAL INTELLIGENCE , BENEVOLENTBIO , JACKIE HUNTER , DISRUPT LONDON
Nov 8, 2016 articles Janssen licenses drugs to artificial intelligence company JACKIE HUNTER , BENEVOLENTBIO , DRUG DISCOVERY , DEEP LEARNING , ARTIFICIAL INTELLIGENCE , BENEVOLENTAI
Nov 2, 2016 articles Using deep learning to update the drug discovery paradigm: an interview with Professor Jackie Hunter JACKIE HUNTER , BENEVOLENTBIO , DRUG DISCOVERY , DEEP LEARNING , ARTIFICIAL INTELLIGENCE
Oct 6, 2016 articles The last hurrah for scientists? ARTIFICIAL INTELLIGENCE , DEEP LEARNING , BIOSCIENCE , BENEVOLENTBIO
Oct 4, 2016 articles Machine-learning teaches computers to tackle big data BIOSCIENCE , ARTIFICIAL INTELLIGENCE , DEEP LEARNING , BENEVOLENTBIO , JACKIE HUNTER
Sep 2, 2016 articles Opening Up Drug Discovery DRUG DISCOVERY , JACKIE HUNTER , BIOSCIENCE , BENEVOLENTBIO , ARTIFICIAL INTELLIGENCE
Nov 30, 2015 announcements BenevolentAI, the pioneering London-based company using artificial intelligence to advance pharmaceutical development, appoints head of BBSRC as new Chief Executive BENEVOLENTAI , ARTIFICIAL INTELLIGENCE , DEEP LEARNING , JACKIE HUNTER , BIOSCIENCE , BENEVOLENTBIO
